A record of what Marketsmith India Analysis said publicly, with the source. Not advice.
“Recommends buying Krishna Institute of Medical Sciences Ltd. (KIMS) at ₹720–740, targeting ₹830 in two to three months with a stop loss at ₹680. Rationale includes growing healthcare demand, strong revenue outlook, established brand, and expansion potential, supported by reclaiming its 21-DMA on above-average volume.”
Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹830, stop ₹680, as stated.
Window: 90 days, the time frame the call states ("two to three months").
The stop ₹680 was reached on a close before the target ₹830. Miss.
The grader’s working: R4 TARGET_CALL: entered ₹670.3 on 2025-11-11 (next trading session's close); stop ₹680 breached at close ₹670.3 on 2025-11-11. Window 90 days — rule H1: the quote states "two to three months".
How it played out
How this is worked out- Target or stop first
- The stop was reached on a close before the target was.
- Time to target
- The target was not reached on a close inside the window.
- Worst close against it
- No close was ever against the call up to 11 Nov 2025, when the call was decided. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.